Sunshine may be problem for CME

Share this article:

The proposed rule for the Physician Payment Sunshine Act is a crucial step toward illuminating physician-industry financial ties. But patient advocacy groups and professional medical associations producing CME, though they may not be “covered recipients” under the law, could be impacted, observes Tom Sullivan, president of Rockpointe.

If such groups get a reportable payment from a manufacturer and use any portion of it or transfer of value toward a covered recipient—a physician or teaching hospital—if “the applicable manufacturer is ‘aware' of the covered recipient's identity, the manufacturer is required to report how much your organization or group…paid.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?